Senior Director, Legal & Compliance

Responsibilities

We are looking for an experienced attorney to join us as Senior Director, Legal & Compliance. This position will report to the VP, Legal & Chief Compliance Officer. 

The Senior Director, Legal & Compliance will be a key member of the Legal Team, partnering with the VP, Legal & Chief Compliance Officer to strategically build and operate Karyopharm’s compliance program.  This role will be responsible for leading multi-disciplinary efforts within the company related to compliance, including designing and implementing an effective training program, overseeing the company’s HCP spend reporting, and developing monitoring processes.  The successful candidate will be able to confidently partner cross-functionally to provide legal guidance and foster a culture of compliance in the company’s interactions with healthcare professionals.  

This role will have high visibility throughout the organization, supporting core business activities and providing counsel to cross functional teams.  The successful candidate in this role will develop strong and positive working relationships with colleagues at all levels.  

• Designs and implements an effective training program to ensure that all employees are educated on relevant laws and policies
• Partners cross-functionally to foster a culture of compliance in the company’s interactions with healthcare professionals, including establishing and leading a compliance liaison committee, advising on speaker program design and documentation, and providing legal guidance to field sales leadership
• Oversees the company’s HCP spend reporting, working across departments to manage the efficient collection and synthesis of data
• Assists the Chief Compliance Officer with implementation of periodic risk assessments, audits, and reporting procedures to identify potential areas of compliance vulnerability and risk. Implements preventative and corrective action plans to mitigate identified risks.
• Develops and implements processes to monitor compliance with relevant laws and policies
• Leads cross-functional privacy project, providing legal counsel for prioritization and implementation of program

Qualifications

• Juris Doctorate and MA Bar admission (or eligibility for in-house counsel admission) required
• 7 years legal experience, including in-house pharmaceutical or biotech industry experience
• Deep understanding of the applicable laws and regulations, particularly the U.S. Anti-Kickback Statute and False Claims Act
• Proven ability to partner cross-functionally, counsel effectively, and inspire support for legal/compliance initiatives
• Masterful at executing both strategically and tactically
• Ability to work in a fast-paced environment and handle multiple, conflicting priorities while managing a substantial workload
• Ability to oversee complex projects and lead them to successful completion
• Ability to effectively manage people, including outside counsel and vendors

Overview

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO® (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade® (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. NEXPOVIO® (selinexor) has also been granted conditional marketing authorization in combination with dexamethasone for adult patients with heavily pretreated multiple myeloma by the European Commission. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visit www.karyopharm.com.

Karyopharm Therapeutics Inc. (the "Company") is an equal opportunity employer. All qualified applicants will be considered without regard to age, race, color, sex, religion/creed, national origin, marital status, ancestry, citizenship, military, reservist or veteran status, pregnancy, sexual orientation or preference, gender identity, gender expression, physical or mental disability, genetic predisposition or carrier status, or any other category protected under applicable federal, state or local law. Consistent with its obligations under applicable law, the Company will make reasonable accommodations for qualified individuals with disabilities. If you require an accommodation in the application process, please contact a member of the Company’s Human Resources department.